Skip to main content
. 2023 Feb 21;15:26. doi: 10.1186/s13098-023-00999-x

Table 2.

Incidence of MetS and related diseases

Incidence N Mean follow-up Person-years/1000 95% CI
MetS 83,224 6.0 50.1 49.3–50.8
Obesity 71,546 6.0 29.1 28.5–29.7
Hypertension 73,437 6.1 63.4 62.5–64.3
Diabetes 90,990 6.1 13.7 13.4–14.1
Dyslipidemia 50,010 6.1 124.8 123.2–126.5

MetS: waist circumference of ≥ 85 cm in men and ≥ 90 cm in women and two or more of the following: (1) blood pressure of ≥ 130/85 mmHg or use of antihypertensive medication; (2) TG level of ≥ 150 mg/dL, HDL-C level of < 40 mg/dL, or use of antilipidemic medication; and (3) glucose level of ≥ 110 mg/dL or use of hypoglycemic medication

Obesity: BMI of ≥ 25 kg/m2

Hypertension: ≥ 140/90 mmHg or use of antihypertensive medication

Diabetes: ≥ 126 mg/dL, HbA1c level of 6.5%, or use of hypoglycemic medication

Dyslipidemia: TG level of ≥ 150 mg/dL, low HDL-C level of < 40 mg/dL, or use of antilipidemic medication

BMI, body mass index; CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; MetS, metabolic syndrome; TG, triglyceride